Industry Briefs | GenomeWeb

Industry Briefs

Premium

Gentel, Eprogen Commercializing Whole Proteome Arrays

Under a partnership announced this week, Gentel Biosciences and Eprogen will create products for the discovery of new autoantibody biomarkers using whole proteome microarrays.

Partitioned whole proteome arrays will be offered for fluorescence detection on Gentel's Path protein microarray slides and chromogenic detection on its Apix array system. Gentel will also process samples on whole proteome arrays for customers through its Symphony Array Services group.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: diatom genetic diversity, microfluidic droplet method for single-cell screening, and more.

Scientific publishers are looking into whether artificial intelligence can help the peer-review process, Wired reports.

Researchers are using gene editing to develop more robust livestock and crops, AFP reports.

Researchers rally near the American Association for the Advancement of Science annual meeting in Boston.